Current status of personalized medicine based on pharmacogenetics in cardiovascular medicine

Brian Tomlinson; Miao Hu; Mary M.Y. Waye; Paul Chan; Zhong Min Liu

doi:10.1080/23808993.2016.1142826

Current status of personalized medicine based on pharmacogenetics in cardiovascular medicine

Brian Tomlinson
, Miao Hu
, Mary M.Y. Waye
, Paul Chan
, Zhong Min Liu

研究成果: 雜誌貢獻 › 社論 › 同行評審

原文	英語
頁（從 - 到）	5-8
頁數	4
期刊	Expert Review of Precision Medicine and Drug Development
卷	1
發行號	1
DOIs	https://doi.org/10.1080/23808993.2016.1142826
出版狀態	已發佈 - 1月 2 2016

ASJC Scopus subject areas

藥理
藥物發現
分子醫學
遺傳學

存取文件

10.1080/23808993.2016.1142826

其它文件與鏈接

Link to publication in Scopus

引用此

@article{11ad3442e8a0454c92f6a3bc2e1f470f,

title = "Current status of personalized medicine based on pharmacogenetics in cardiovascular medicine",

author = "Brian Tomlinson and Miao Hu and Waye, \{Mary M.Y.\} and Paul Chan and Liu, \{Zhong Min\}",

note = "Funding Information: The Clinical Pharmacogenetics Implementation Consortium (CPIC) of the National Institutes of Health Pharmacogenomics Research Network has been established to provide evidence-based practical guidelines from a panel of experts to facilitate the implementation and translation of pharmacogenomic knowledge from bench to bedside [4]. In the cardiovascular field, there has been a tremendous amount of work resulting in numerous publications which have been reviewed by the CPIC resulting in implementation guidelines for warfarin [5], clopidogrel [6,7], and simvastatin [8,9]. The Implementing GeNomics In pracTicE network funded by the NIH and other US funding bodies involves six genomic medicine demonstration projects which will help to implement the use of genomic information in patient care [10].",

year = "2016",

month = jan,

day = "2",

doi = "10.1080/23808993.2016.1142826",

language = "English",

volume = "1",

pages = "5--8",

journal = "Expert Review of Precision Medicine and Drug Development",

issn = "2380-8993",

publisher = "Taylor and Francis Ltd.",

number = "1",

}

TY - JOUR

T1 - Current status of personalized medicine based on pharmacogenetics in cardiovascular medicine

AU - Tomlinson, Brian

AU - Hu, Miao

AU - Waye, Mary M.Y.

AU - Chan, Paul

AU - Liu, Zhong Min

N1 - Funding Information: The Clinical Pharmacogenetics Implementation Consortium (CPIC) of the National Institutes of Health Pharmacogenomics Research Network has been established to provide evidence-based practical guidelines from a panel of experts to facilitate the implementation and translation of pharmacogenomic knowledge from bench to bedside [4]. In the cardiovascular field, there has been a tremendous amount of work resulting in numerous publications which have been reviewed by the CPIC resulting in implementation guidelines for warfarin [5], clopidogrel [6,7], and simvastatin [8,9]. The Implementing GeNomics In pracTicE network funded by the NIH and other US funding bodies involves six genomic medicine demonstration projects which will help to implement the use of genomic information in patient care [10].

PY - 2016/1/2

Y1 - 2016/1/2

UR - https://www.scopus.com/pages/publications/85047474045

UR - https://www.scopus.com/pages/publications/85047474045#tab=citedBy

U2 - 10.1080/23808993.2016.1142826

DO - 10.1080/23808993.2016.1142826

M3 - Editorial

AN - SCOPUS:85047474045

SN - 2380-8993

VL - 1

SP - 5

EP - 8

JO - Expert Review of Precision Medicine and Drug Development

JF - Expert Review of Precision Medicine and Drug Development

IS - 1

ER -